Advertisement
CORRESPONDENCE|Articles in Press

Adenoid cystic carcinoma arising in association with an intraductal papilloma of the breast

      To the Editor,
      Adenoid cystic carcinoma (AdCC) is a rare ‘salivary gland-like’ type of breast carcinoma with generally indolent biological behaviour in its classic form. This tumour features a biphasic epithelial-myoepithelial cell population comprising luminal cells that line glandular or cribriform spaces and abluminal myoepithelial or basal cells that form pseudoglandular spaces containing basement membrane material.
      • Tan P.H.
      • Ellis I.
      • Allison K.
      • et al.
      The 2019 World Health Organization classification of tumours of the breast.
      Although the immunomolecular phenotype is often triple-negative [negative expression for oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2)], the vast majority of patients have a good prognosis; therefore, it is important to distinguish it from conventional triple-negative disease with adverse prognosis. Most AdCCs possess MYB gene abnormality, especially MYB-NFIB fusion. AdCC of the breast can be accompanied by other breast lesions, including microglandular adenosis
      • An J.K.
      • Woo J.J.
      • Kim E.K.
      • et al.
      Breast adenoid cystic carcinoma arising in microglandular adenosis: a case report and review of literature.
      and ductal carcinoma in situ (DCIS).
      • Burusapat C.
      • Buarabporn N.
      • Wongchansom K.
      • et al.
      Mammary adenoid cystic carcinoma presenting with Ductal carcinoma in situ and axillary lymph node metastasis.
      To our best knowledge however, AdCC arising in association with an intraductal papilloma has not been reported. We now document a unique case of an AdCC that appears to arise from an intraductal papilloma.
      A 69-year-old female presented with a 1.0 cm firm lump in the left breast at 9–10 o'clock which appeared suspicious on ultrasonography. An ultrasound core biopsy was performed which found focal cytoarchitectural atypia in an intraductal papillary lesion, following which the entire lesion was excised.
      The core biopsy comprised five to six cores containing an epithelial proliferative lesion displaying a papillary architecture with anastomosed and coalesced papillary fronds supported by fibrovascular cores. Some detached fragments showed part of the cystically dilated duct from which the papillary lesion arose (Fig. 1A). Several areas displayed relatively rigid luminal spaces amongst the epithelial islands (Fig. 1B), which were either empty or contained small amounts of pink secretions. There was stromal sclerosis, interpreted as sclerosis of the intraductal papillary lesion (Fig. 1C). While the architectural atypia manifested by the cribriform spaces would have required adjunctive immunohistochemistry (IHC) for elucidation, upon discussion with the surgeon, it was felt that complete excision of the entire lesion would be required in any case, hence it was agreed that further workup could be conducted after evaluating the excision specimen.
      Fig. 1
      Fig. 1(A) A cystically dilated duct giving rise to the papillary lesion on core biopsy. (B) Cribriform architecture noted among the epithelial cells. (C) Stromal sclerosis of the intraductal papillary lesion. (D) On the excision specimen, nubbins of basaloid cribriform islands protruded into the fat, adjacent to a solidified intraductal papillary lesion. (E) The luminal spaces were bilayered with a luminal epithelial layer and outer rim of myoepithelial cells. (F) Hyaline spherules were observed amongst the epithelial cells. (G) Immunohistochemistry showed mostly negative staining for ER. (H) p63 highlighted myoepithelial cells around cribriform islands. (I) Fluorescence in situ hybridisation (FISH) shows the green fluorochrome probe hybridised to the proximal end while the orange fluorochrome hybridised to the distal end of the MYB gene. Interphase nuclei showed two fusion MYB gene signals indicating intact MYB gene. Disruption of the MYB gene was therefore not observed. Courtesy of the Cytogenetics Laboratory, Singapore General Hospital. Images A–C are from the core biopsy, while D–I are from the excision specimen.
      The excision specimen measured 3.0×2.5×2.5 cm. Macroscopic appearance showed a relatively well-circumscribed, vaguely lobulated, greyish nodule with ill-defined contours (Fig. 2), measuring a maximum diameter of 11 mm.
      Fig. 2
      Fig. 2Left breast excision containing the greyish nodular lesion with apparent circumscribed contours on macroscopic appearance (yellow arrow).
      In the excision specimen, a solidified papillary lesion was present, with several foci of rounded cribriform basaloid epithelial protrusions into surrounding adipose tissue. The basaloid cribriform foci appeared to merge imperceptibly with a morphologically benign intraductal papillary process (Fig. 1D). Within the cribriform areas, the luminal spaces contained both pink secretions as well as watery greyish, mucinous type material. The luminal spaces appeared lined by both polarised and flattened cells (Fig. 1E,F).
      IHC performed in the excision specimen revealed mostly negative staining for ER (Fig. 1G). PR and HER-2 were negative. CK7 defined the luminal epithelial with negative reactivity for the outer layer of cells. CD117 showed patchy reactivity of luminal cells. CK5/6 disclosed both positivity in the luminal cells around some of the round spaces, as well as other non-luminal cells. P63 showed a well-defined layer of myoepithelial cells around the cribriform islands (Fig. 1H), while smooth muscle myosin heavy chain (SMMHC) also demonstrated an intact rim of myoepithelial cells. Ki-67 proliferation was less than 10% in lesional areas.
      Fluorescent in situ hybridisation (FISH) showed no disruption of the MYB gene (Fig. 1I).
      The final diagnosis was regarded as an intraductal papilloma with an epithelial-myoepithelial lesion consistent with AdCC.
      AdCC is an invasive carcinoma composed of epithelial and myoepithelial neoplastic cells arranged in tubular, cribriform and solid patterns, associated with basophilic matrix and basement membrane material, frequently linked to MYB-NFIB fusion. The major MYB gene alteration of AdCC possesses the MYB-NFIB fusion gene.
      • Kim J.
      • Geyer F.C.
      • Martelotto L.G.
      • et al.
      MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
      Although the majority of AdCCs will show this fusion, those without the MYB-NFIB fusion gene may display MYBL1 rearrangements or MYB amplification. In our case, we did not detect breakage of the MYB gene on FISH. MYB gene abnormality may be the initiating factor in the pathogenesis of AdCC,
      • Butcher M.R.
      • White M.J.
      • Rooper L.M.
      • et al.
      MYB RNA in situ hybridization is a useful diagnostic tool to distinguish breast adenoid cystic carcinoma from other triple-negative breast carcinomas.
      though it is not an essential criterion and MYB gene abnormality is not always present in all cases, with limited prognostic significance.
      • Ji J.
      • Zhang F.
      • Duan F.
      • et al.
      Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast.
      Apart from the classic form of AdCC as seen in our case, solid basaloid AdCC is another subtype which can be more aggressive, with a third subtype that shows high grade transformation.
      • Schwartz C.J.
      • Brogi E.
      • Marra A.
      • et al.
      The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
      The differential diagnoses on core biopsy include atypical ductal hyperplasia (ADH) and low grade ductal carcinoma in situ (DCIS) in view of the cytoarchitecturally atypical cribriform proliferation residing within portions of a benign intraductal process. In a papillary lesion, ADH is distinguished from low grade DCIS by extent using a 3 mm threshold. If IHC was conducted on the core biopsy material with a panel of ER and high molecular weight keratins, both ADH and low grade DCIS would display diffuse ER and diminished high molecular weight keratin expression.
      • Sanati S.
      Morphologic and molecular features of breast ductal carcinoma in situ.
      For our case, ER would have been negative and high molecular weight keratin positive, leading away from a consideration of ADH/DCIS, and raising a differential of adenomyoepithelioma which is an epithelial-myoepithelial lesion with prominent myoepithelial cells. The adenomyoepithelioma has both ER-positive and ER-negative forms and may display overlapping histology with AdCC, but it shows more prominent myoepithelial cells which are often clear and epithelioid, contrasting against the basaloid appearance of AdCC (Table 1). MYBL1 rearrangements are not found in adenomyoepithelioma.
      • Rakha E.
      • Tan P.H.
      • Ellis I.
      • Quinn C.
      Adenomyoepithelioma of the breast: a proposal for classification.
      Table 1Comparison of clinicopathological features of adenomyoepithelioma (AME) and adenoid cystic carcinoma (AdCC)
      Clinicopathological featuresAMEAdCC
      Cellular compositionEpithelial-myoepithelial tumour with prominent myoepithelial cellsEpithelial-myoepithelial tumour with frequent basaloid appearance
      Architectural patternsTubular, lobulated, spindle cell, papillary variantsCribriform/tubular or solid basaloid growth patterns
      CytomorphologyMyoepithelial cells are enlarged with clear cytoplasm. Small epithelium-lined spaces with inner luminal ductal cellsMyoepithelial cells tend to be smaller, more hyperchromatic and basaloid appearing and have much less cytoplasm, lining pseudolumina in addition to bi-layered tubules with true lumens
      • Rakha E.
      • Tan P.H.
      • Ellis I.
      • Quinn C.
      Adenomyoepithelioma of the breast: a proposal for classification.
      ImmunohistochemistryER+ or –, CD117– or focal +ER–, CD117+
      Clinical behaviourCan be benign or malignantMalignant
      In the excision specimen, the pink spherules may raise consideration for collagenous spherulosis which is usually not mass forming and an often incidental finding within a background of usual ductal hyperplasia or an intraductal papilloma. It has been reported that CD117 can distinguish collagenous spherulosis from AdCC, the latter being positive.
      • Torous V.F.
      • Schnitt S.J.
      • Collins L.
      Benign breast lesions that mimic malignancy.
      The existence of an in situ component of AdCC has been debated at length. In Rosen's Breast Pathology,
      • Hoda S.A.
      • Brogi E.
      • Koerner F.C.
      • Rosen P.P.
      Rosen's Breast Pathology.
      it is stated that in situ AdCC can be recognised by the absence of a periductal cuff of bluish hypercellular or slightly myxoid stroma that typically surrounds invasive nests. Additionally, partial duct involvement, myoepithelial cells around affected ducts disclosing a similar uniform distribution and cellular density as myoepithelium in adjacent non-neoplastic ducts, may be used as histological evidence of in situ disease.
      In terms of clinical behaviour, AdCC is a low grade triple-negative disease with favourable behaviour and should not be treated like other triple-negative breast cancers which are more aggressive. Recurrence and distant metastasis are rare. It often presents at an early stage with better survival than invasive breast carcinoma.
      • Treitl D.
      • Radkani P.
      • Rizer M.
      • et al.
      Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature.
      Radical surgery is curative. It must be noted that the solid basaloid form is more aggressive.
      In summary, we present a unique case of AdCC appearing to arise from an intraductal papilloma, with histological challenges posed particularly on core biopsy, with the final diagnosis achieved on excision.

      References

        • Tan P.H.
        • Ellis I.
        • Allison K.
        • et al.
        The 2019 World Health Organization classification of tumours of the breast.
        Histopathology. 2020; 77: 181-185
        • An J.K.
        • Woo J.J.
        • Kim E.K.
        • et al.
        Breast adenoid cystic carcinoma arising in microglandular adenosis: a case report and review of literature.
        World J Clin Cases. 2021; 9: 7579-7587
        • Burusapat C.
        • Buarabporn N.
        • Wongchansom K.
        • et al.
        Mammary adenoid cystic carcinoma presenting with Ductal carcinoma in situ and axillary lymph node metastasis.
        J Surg Case Rep. 2020; 2020: rjz362
        • Kim J.
        • Geyer F.C.
        • Martelotto L.G.
        • et al.
        MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
        J Pathol. 2018; 244: 143-150
        • Butcher M.R.
        • White M.J.
        • Rooper L.M.
        • et al.
        MYB RNA in situ hybridization is a useful diagnostic tool to distinguish breast adenoid cystic carcinoma from other triple-negative breast carcinomas.
        Am J Surg Pathol. 2022; 46: 878-888
        • Ji J.
        • Zhang F.
        • Duan F.
        • et al.
        Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast.
        Sci Rep. 2022; 12: 8504
        • Schwartz C.J.
        • Brogi E.
        • Marra A.
        • et al.
        The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
        Mod Pathol. 2022; 35: 193-201
        • Sanati S.
        Morphologic and molecular features of breast ductal carcinoma in situ.
        Am J Pathol. 2019; 189: 946-955
        • Rakha E.
        • Tan P.H.
        • Ellis I.
        • Quinn C.
        Adenomyoepithelioma of the breast: a proposal for classification.
        Histopathology. 2021; 79: 465-479
        • Torous V.F.
        • Schnitt S.J.
        • Collins L.
        Benign breast lesions that mimic malignancy.
        Pathology. 2017; 49: 181-196
        • Hoda S.A.
        • Brogi E.
        • Koerner F.C.
        • Rosen P.P.
        Rosen's Breast Pathology.
        Wolters Kluwer, Philadelphia2021: 799-827
        • Treitl D.
        • Radkani P.
        • Rizer M.
        • et al.
        Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature.
        Breast Cancer. 2018; 25: 28-33